Abstract2 ¶-C-Cyano-2 ¶-deoxy-1-B-D-arabino-pentofuranosylcytosine (CNDAC), the prodrug (sapacitabine) of which is in clinical trials, has the novel mechanism of action of causing single-strand breaks after incorporating into DNA. Cells respond to this unique lesion by activating the G 2 checkpoint, affected by the Chk1-Cdc25C-cyclindependent kinase 1/cyclin B pathway. This study aims at defining DNA damage checkpoint sensors that activate this response to CNDAC, particularly focusing on the major phosphatidylinositol 3-kinase -like protein kinase family proteins. First, fibroblasts, deficient in ataxiatelangiectasia mutated (ATM), transfected with empty vector or repleted with ATM, were arrested in G 2 by CNDAC to similar extents, suggesting ATM is not required to activate the G 2 checkpoint. Second, chromatin associations of RPA70 and RPA32, subunits of the ssDNAbinding protein, and the ataxia-telangiectasia and Rad3-related (ATR) substrate Rad17 and its phosphorylated form were increased on CNDAC exposure, suggesting activation of ATR kinase. The G 2 checkpoint was abrogated due to depletion of ATR by small interfering RNA, and impaired in ATR-Seckel cells, indicating participation of ATR in this G 2 checkpoint pathway. Third, the G 2 checkpoint was more stringent in glioma cells with wild-type DNA-dependent protein kinase catalytic subunit (DNA-PKcs) than those with mutant DNA-PKcs, as shown by mitotic index counting. CNDAC-induced G 2 arrest was abrogated by specific DNA-PKcs inhibitors or small interfering RNA knockdown in ML-1 and/or HeLa cells. Finally, two phosphatidylinositol 3-kinase -like protein kinase inhibitors, caffeine and wortmannin, abolished the CNDAC-induced G 2 checkpoint in a spectrum of cell lines. Together, our data showed that ATR and DNA-PK cooperate in CNDAC-induced activation of the G 2 checkpoint pathway.